Self-nonself discrimination by the complement system
- PMID: 27393384
- DOI: 10.1002/1873-3468.12284
Self-nonself discrimination by the complement system
Abstract
The alternative pathway (AP) of complement can recognize nonself structures by only two molecules, C3b and factor H. The AP deposits C3b covalently on nonself structures via an amplification system. The actual discrimination is performed by factor H, which has binding sites for polyanions (sialic acids, glycosaminoglycans, phospholipids). This robust recognition of 'self' protects our own intact viable cells and tissues, while activating structures are recognized by default. Foreign targets are opsonized for phagocytosis or killed. Mutations in factor H predispose to severe diseases. In hemolytic uremic syndrome, they promote complement attack against blood cells and vascular endothelial cells and lead, for example, to kidney and brain damage. Even pathogens can exploit factor H. In fact, the ability to bind factor H discriminates most pathogenic microbes from nonpathogenic ones.
Keywords: escape; hemolytic uremic syndrome; sialic acid.
© 2016 Federation of European Biochemical Societies.
Similar articles
-
Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Proc Natl Acad Sci U S A. 1990 May;87(10):3982-6. doi: 10.1073/pnas.87.10.3982. Proc Natl Acad Sci U S A. 1990. PMID: 1692629 Free PMC article.
-
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2897-902. doi: 10.1073/pnas.1017087108. Epub 2011 Feb 1. Proc Natl Acad Sci U S A. 2011. PMID: 21285368 Free PMC article.
-
Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.Blood. 2016 Jun 2;127(22):2701-10. doi: 10.1182/blood-2015-11-680009. Epub 2016 Mar 22. Blood. 2016. PMID: 27006390
-
Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology.Histol Histopathol. 2004 Jan;19(1):251-8. doi: 10.14670/HH-19.251. Histol Histopathol. 2004. PMID: 14702193 Review.
-
Complement activation in diseases presenting with thrombotic microangiopathy.Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4. Eur J Intern Med. 2013. PMID: 23743117 Review.
Cited by
-
Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.J Immunol. 2022 Jun 1;208(11):2482-2496. doi: 10.4049/jimmunol.2101170. Epub 2022 May 2. J Immunol. 2022. PMID: 35500934 Free PMC article.
-
New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle.Front Cell Infect Microbiol. 2020 Jan 30;10:1. doi: 10.3389/fcimb.2020.00001. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32083019 Free PMC article. Review.
-
Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases.Sci Rep. 2017 Dec 5;7(1):16958. doi: 10.1038/s41598-017-17318-w. Sci Rep. 2017. PMID: 29209066 Free PMC article.
-
Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.J Immunol. 2017 Dec 1;199(11):3828-3839. doi: 10.4049/jimmunol.1700426. Epub 2017 Oct 30. J Immunol. 2017. PMID: 29084837 Free PMC article.
-
Alternative pathway activation: Ever ancient and ever new.Immunol Rev. 2023 Jan;313(1):60-63. doi: 10.1111/imr.13132. Epub 2022 Sep 11. Immunol Rev. 2023. PMID: 36089772 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
